Skip to main content

HAVERTY FURNITURE COMPANIES INC

For the period ended Mar 31, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

HVT$26.16-0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows – and (unaudited)

INDEX

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)Three Months EndedMarch 31,
20262025
Cash Flows from Operating Activities:
Net income$4,261$3,778
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization6,2835,895
Share-based compensation expense2,3762,080
Other(1,454)(924)
Changes in operating assets and liabilities:
Inventories(10,706)(5,285)
Customer deposits4,9152,027
Other assets and liabilities(1,211)3,124
Accounts payable and accrued liabilities(7,365)(4,541)
Net cash (used in) provided by operating activities(2,901)6,154
Cash Flows from Investing Activities:
Capital expenditures(6,954)(6,127)
Proceeds from sale of land, property, and equipment215
Net cash used in investing activities(6,933)(6,122)
Cash Flows from Financing Activities:
Dividends paid(5,309)(5,173)
Common stock repurchased(1,990)(2,000)
Taxes on vested restricted shares(677)(885)
Net cash used in financing activities(7,976)(8,058)
Decrease in cash, cash equivalents, and restricted cash equivalents during the period(17,810)(8,026)
Cash, cash equivalents, and restricted cash equivalents at beginning of period131,872126,314
Cash, cash equivalents, and restricted cash equivalents at end of period$114,062$118,288
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.